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ORIGINAL
E n d o c r i n e

ARTICLE
C a r e

Tracking of Bone Mass and Density during Childhood
and Adolescence
Heidi J. Kalkwarf, Vicente Gilsanz, Joan M. Lappe, Sharon Oberfield,
John A. Shepherd, Thomas N. Hangartner, Xangke Huang,
Margaret M. Frederick, Karen K. Winer, and Babette S. Zemel
Cincinnati Children’s Medical Center (H.J.K.), Cincinnati, Ohio 45229; Children’s Hospital Los Angeles
(V.G.), Los Angeles, California 90027; Creighton University (J.M.L.), Omaha, Nebraska 68131; Columbia
University (S.O.), New York, New York 10032; University of California at San Francisco (J.A.S.), San
Francisco, California 94143; Wright State University (T.N.H.), Dayton, Ohio 45435; Clinical Trials and
Survey Corporation (X.H., M.M.F.), Baltimore, Maryland 21210; National Institute of Child Health and
Human Development (K.K.W.), Bethesda, Maryland 20892; and Children’s Hospital of Philadelphia
(B.S.Z.), Philadelphia, Pennsylvania 19104

Context: Whether a child with low bone mineral density (BMD) at one point in time will continue
to have low BMD, despite continued growth and maturation, is important clinically. The stability
of a characteristic during growth is referred to as “tracking.”
Objective: We examined the degree of tracking in bone mineral content (BMC) and BMD during
childhood and adolescence and investigated whether tracking varied according to age, sexual
maturation, and changes in growth status.
Design: We conducted a longitudinal study with measurements at baseline and annually for 3 yr.
Setting: The Bone Mineral Density in Childhood Study was conducted at five clinical centers in the
United States.
Study Participants: A total of 1554 girls and boys, ages 6 –16 yr at baseline, participated in the study.
Main Outcome Measures: Whole body, spine, hip, and forearm BMC and BMD were measured by
dual-energy x-ray absorptiometry, and age-, sex-, and race-specific Z-scores were calculated. Deviation from tracking was calculated as the Z-score at yr 3 minus baseline.
Results: Correlations between Z-scores at baseline and yr 3 ranged from 0.76 – 0.88. Among children
with a Z-score below ⫺1.5 at baseline, 72– 87% still had a Z-score below ⫺1 after 3 yr. Age, sexual
maturation, and deviations in growth status (P ⬍ 0.01) were associated with deviation from tracking; however, tracking was strongly evident even after adjusting for the effects of age, maturation,
and growth.
Conclusions: Bone density showed a high degree of tracking over 3 yr in children and adolescents.
Healthy children with low bone density will likely continue to have low bone density unless effective interventions are instituted. (J Clin Endocrinol Metab 95: 1690 –1698, 2010)

steoporosis is a major public health problem. Approximately 10 million people in the United States
have osteoporosis, and another 34 million have low bone
mass (1). Many have speculated that the origins of osteo-

O

porosis begin in childhood (2) because bone mass accrued
during childhood and adolescence determines peak bone
mass in young adulthood. In turn, variation in peak bone
mass is thought to predict osteoporotic fracture risk later
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in life (3, 4). Others have challenged this notion, citing that
compensations in bone mass occur in response to recent
conditions and physical challenges (5), and that bone
formed early in life is completely replaced during growth
due to skeletal modeling and remodeling (6). About 40%
of adult total body bone mineral content (BMC) is acquired during the 2 yr around peak height velocity in adolescence (7). Thus, it remains unclear whether bone mass
accrued during childhood has any effect on BMC and risk
of osteoporosis and fractures in adulthood.
Bone mineral status, defined as a child’s BMC or bone
mineral density (BMD) relative to age- and sex-specific
norms, is used as the indicator of bone mineral accrual to
account for the increases in bone mass and density
throughout childhood and adolescence. The continuity or
stability of bone mineral status throughout childhood and
adolescence is referred to as “tracking” (8). Establishing
whether and to what degree bone mineral status tracks is
important because tracking forms the cornerstone for
screening and targeting of interventions to improve bone
mineral status. Because childhood and adolescence are
such dynamic periods of bone accrual, it is unclear how
well BMC and BMD track during these periods of growth
and maturation. A better understanding of tracking may
provide greater opportunities for early screening and targeting of interventions to prevent osteoporosis later in life.
There is some evidence that BMC and BMD track during growth and maturation. BMC and BMD of the total
body, hip, and spine measured in pre- and early puberty
are correlated (r ⫽ 0.54 – 0.81) with measurements obtained 7 to 8 yr later (9 –11). Most studies to date, however, have been constrained by small sample sizes (e.g.
ⱕ25 subjects/group) (12–14), and/or measurement of
BMD by techniques not widely used in clinical practice
(13, 15). Although mean values of BMC and BMD have
been compared over time, it is important to examine the
persistence of values that are considered to be “low” because these are of clinical concern. A large sample size is
needed to adequately examine the tails of a distribution
(i.e. the lowest or highest values). Furthermore, the potential variations in tracking of bone mineral status with
age, stage of sexual maturation, and accelerated or delayed linear growth and weight gain have received little
attention. A better understanding of factors that affect the
degree of tracking will help elucidate the clinical utility of
bone mineral status measures.
The objectives of this study were to estimate the degree
of tracking in bone mineral status over a 3-yr period during childhood and adolescence and to investigate whether
tracking varied according to age, sexual maturity, and
changes in height and weight status. We assessed the degree of tracking for a variety of skeletal sites to help inform
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selection of bone measurements that should be monitored
clinically.

Subjects and Methods
Subjects
The Bone Mineral Density in Childhood Study (BMDCS) is a
multicenter, longitudinal study of bone accrual in 1554 healthy
children and adolescents. Detailed information about the study
participants, inclusion/exclusion criteria, and study procedures
have been published previously (16). In brief, 1554 healthy subjects were enrolled: girls ages 6 to 15 yr, and boys ages 6 to 16 yr.
All measurements were obtained at baseline and annually thereafter. Presented here are data from the baseline and three annual
follow-up visits.

Measurements
Bone mass and density were measured by dual-energy x-ray
absorptiometry (DXA) scans of the spine, hip, forearm, and
whole body (Hologic QDR 4500/Delphi/Discovery; Hologic,
Inc., Bedford, MA). There were small differences in calibration
of densitometers among centers as reported previously (16), and
we adjusted all DXA measures to remove center differences. Zscores were calculated for each bone measurement using sex- and
race-specific LMS curves. LMS curves were based on 4 yr of data
(baseline, yr 1 to 3) from the BMDCS cohort and were generated
using the LMS program version 1.16 (17). Worm plots were used
to assess goodness of fit (18).
Weight was measured on a digital scale, and height was measured using a stadiometer. Z-scores for height, weight, and body
mass index (BMI) were calculated using the CDC 2000 growth
charts.
Ethnicity (Hispanic/Latino vs. non-Hispanic/Latino) and
race were elicited by questionnaire using National Institutes of
Health definitions. Participants were categorized as black or
non-black for data analysis purposes.
Sexual maturation was determined by physical examination
performed by a physician or nurse practitioner with established
expertise in pediatric endocrinology. The stage of breast development (girls) and testicular volume by orchidometer (boys)
were evaluated based upon the criteria of Tanner (19).

Statistical analyses
Tracking was assessed by calculating the Pearson correlation
coefficients between Z-scores at baseline with those in subsequent years. Correlation coefficients were calculated separately
according to sex and race. We examined the persistence of low
and high bone mineral status by calculating the proportion of
subjects who had “LOW” (Z-score ⬍⫺1.5) or “HIGH” (Z-score
⬎1.5) values at baseline who continued to have LOW or HIGH
values after 1, 2, and 3 yr of follow-up. We used a Z-score cutoff
of ⫺1.5 to define LOW, which differs from that of the International Society of Clinical Densitometry of ⫺2, so that we had
larger sample sizes at the extremes, giving more stable estimates.
The results were similar using a Z-score cutoff of ⫺2 (data not
shown).
Sometimes extremely low or high values are due to measurement error or variability within the individual. In these situations, when the measurement is repeated, the values are often
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closer to the sample mean (20). This phenomenon is referred to
as regression toward the mean. Assessing the magnitude of regression toward the mean aids interpretation of extreme results
and, thereby, the degree of tracking. To quantify regression toward the mean, we categorized children according to their bone
Z-scores at baseline and calculated the mean Z-score by baseline
category for each study year.
We investigated whether the degree of tracking varied according to age, maturation, and change in growth status, defined
as the change in height- and weight-for-age Z-scores. First, we
examined the correlations between Z-scores at baseline and yr 3
for each bone measure according to age and Tanner stage at
baseline. We then calculated deviation from tracking, which was
the difference between the Z-score at yr 3 and the Z-score at
baseline, and examined the correlation between deviation from
tracking and changes in height and weight Z-scores over the 3-yr
period. Multiple regression analyses were conducted to determine which of these factors independently predicted deviation
from tracking. Baseline bone Z-scores were included in the regression models to account for regression toward the mean. Regression analyses were conducted separately by sex so that we
could better account for differences in ages of sexual maturation
and peak growth velocity between boys and girls.
Because height and weight are important determinants of
BMD and are known to track over time, it is useful to know
whether bone mineral status tracks even when accounting for the
effects of height and weight. We used multiple regression to predict bone Z-scores at yr 3 as a function of baseline bone Z-scores
and sequentially fitted height and weight Z-scores at baseline and
change in Z-scores over the 3-yr period.

J Clin Endocrinol Metab, April 2010, 95(4):1690 –1698

Results
Of 1554 children enrolled in the study, 1477 returned for
their follow-up visit in yr 1, 1443 in yr 2, and 1401 in yr
3. The analysis subset was restricted for follow-up visits
within ⫾2.0 months of the anniversary date of the baseline
visit, resulting in 1459 subjects in yr 1, 1400 subjects in yr
2, and 1370 subjects in yr 3. The proportion of subjects
with a missed or out of window visit for yr 3 was greater
for blacks [16.2% (60 of 371)] than non-blacks [7.9% (93
of 1183)]. Non-blacks without a yr 3 visit were slightly
younger (⫺0.6 yr; P ⫽ 0.08) and had a slightly higher
lumbar spine bone density Z-score at baseline (⫹0.26; P ⫽
0.03) compared with those with a yr 3 visit. Blacks without
a yr 3 visit tended to be older (⫹0.5 yr; P ⫽ 0.20) with a
slightly lower whole body BMC Z-score (⫺0.25; P ⫽
0.10) and lower weight Z-score (⫺0.28; P ⫽ 0.02) at baseline compared with those with a yr 3 visit.
The correlation coefficients between Z-scores for BMC
and BMD and growth measures determined at baseline
with values obtained in subsequent years were high overall
and decreased only slightly each year (Table 1). Similar
trends were seen for boys and girls, and blacks and nonblacks. Results for lumbar spine, total hip, femoral neck,
and 1/3 radius BMC were similar to those for BMD and
thus not shown. The correlations for bone Z-scores were

TABLE 1. Correlation coefficients between Z-scores at baseline and Z-scores at yr 1–3 by sex and race
White
Variables
Whole body BMC
Boys
Girls
Lumbar spine BMD
Boys
Girls
Total hip BMD
Boys
Girls
Femoral neck BMD
Boys
Girls
1/3 radius BMD
Boys
Girls
Height
Boys
Girls
Weight
Boys
Girls
BMI
Boys
Girls

Black

Year 1

Year 2

Year 3

Year 1

Year 2

Year 3

0.95 (545)
0.96 (566)

0.88 (513)
0.90 (532)

0.80 (490)
0.84 (519)

0.96 (163)
0.95 (162)

0.91 (143)
0.89 (145)

0.82 (139)
0.84 (151)

0.94 (549)
0.94 (569)

0.87 (534)
0.89 (551)

0.80 (520)
0.84 (540)

0.94 (165)
0.95 (171)

0.87 (150)
0.88 (160)

0.80 (150)
0.85 (158)

0.94 (549)
0.94 (568)

0.89 (531)
0.88 (550)

0.84 (514)
0.84 (540)

0.95 (164)
0.95 (171)

0.88 (145)
0.89 (160)

0.83 (141)
0.87 (159)

0.94 (549)
0.92 (568)

0.89 (531)
0.86 (550)

0.83 (514)
0.83 (540)

0.95 (164)
0.95 (171)

0.90 (145)
0.90 (160)

0.85 (141)
0.88 (159)

0.87 (531)
0.89 (551)

0.81 (513)
0.85 (528)

0.76 (510)
0.82 (524)

0.90 (161)
0.89 (170)

0.83 (145)
0.85 (159)

0.81 (141)
0.84 (159)

0.95 (551)
0.96 (572)

0.88 (534)
0.91 (554)

0.82 (520)
0.86 (544)

0.96 (165)
0.93 (171)

0.89 (150)
0.85 (162)

0.84 (145)
0.78 (161)

0.93 (551)
0.94 (572)

0.85 (534)
0.88 (554)

0.76 (520)
0.81 (544)

0.94 (165)
0.94 (171)

0.88 (150)
0.87 (162)

0.81 (145)
0.80 (161)

0.93 (551)
0.92 (572)

0.85 (534)
0.86 (554)

0.78 (520)
0.80 (544)

0.92 (165)
0.92 (171)

0.88 (150)
0.85 (162)

0.82 (145)
0.80 (161)

Data are expressed as correlation coefficients (number of subjects). All correlation coefficients are statistically significant (P value ⬍0.0001). Results
(not shown) were similar for BMC.
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TABLE 2. Persistence of LOW (below ⫺1.5) and HIGH (⬎1.5) Z-scores at baseline over 3 yr
LOW Z-score
Z-score at follow-up
Whole body BMC
Below ⫺1.5 or ⬎1.5
Below ⫺1 or ⬎1
Lumbar spine BMD
Below ⫺1.5 or ⬎1.5
Below ⫺1 or ⬎1
Total hip BMD
Below ⫺1.5 or ⬎1.5
Below ⫺1 or ⬎1
Femoral neck BMD
Below ⫺1.5 or ⬎1.5
Below ⫺1 or ⬎1
1/3 radius BMD
Below ⫺1.5 or ⬎1.5
Below ⫺1 or ⬎1
Height
Below ⫺1.5 or ⬎1.5
Below ⫺1 or ⬎1
Weight
Below ⫺1.5 or ⬎1.5
Below ⫺1 or ⬎1
BMI
Below ⫺1.5 or ⬎1.5
Below ⫺1 or ⬎1

HIGH Z-score

Year 1
(NY1Y0/NY0)

Year 2
(NY2Y0/NY0)

Year 3
(NY3Y0/NY0)

77 (74/96)
97 (93/96)

57 (52/91)
88 (80/91)

52 (45/87)
77 (67/87)

77 (72/94)
98 (92/94)

74 (67/91)
91 (83/91)

60 (52/87)
87 (76/87)

75 (62/83)
98 (81/83)

68 (54/80)
90 (72/80)

71 (63/89)
94 (84/89)

Year 1
(NY1Y0/NY0)

Year 2
(NY2Y0/NY0)

Year 3
(NY3Y0/NY0)

72 (64/89)
94 (84/89)

61 (50/82)
89 (73/82)

77 (80/104)
98 (102/104)

64 (64/100)
73 (73/100)

62 (59/95)
81 (77/95)

62 (48/78)
86 (67/78)

70 (79/113)
96 (108/113)

63 (66/105)
90 (95/105)

50 (52/105)
84 (88/105)

64 (54/84)
92 (77/84)

57 (48/84)
82 (69/84)

74 (78/105)
97 (102/105)

61 (61/100)
92 (92/100)

56 (54/96)
88 (85/96)

65 (67/103)
87 (90/103)

48 (49/102)
77 (79/102)

44 (46/104)
72 (75/104)

59 (50/85)
89 (76/85)

62 (50/81)
83 (67/81)

51 (37/73)
85 (62/73)

65 (22/34)
94 (32/34)

53 (16/30)
87 (26/30)

44 (14/32)
81 (25/31)

79 (55/70)
98 (69/70)

72 (48/67)
88 (59/67)

64 (43/67)
90 (60/67)

50 (10/20)
85 (17/20)

45 (9/20)
65 (13/20)

40 (8/20)
60 (12/20)

70 (64/92)
98 (90/92)

63 (55/87)
92 (80/87)

59 (52/88)
89 (78/88)

46 (11/24)
100 (24/24)

29 (7/24)
58 (14/24)

39 (9/23)
52 (12/23)

72 (84/116)
96 (112/116)

58 (65/112)
95 (106/112)

61 (66/111)
91 (101/111)

77 (71/92)
100 (92/92)

Data are expressed as percentage (number of subjects/total number of subjects). NY1Y0, Number of subjects that had a LOW (or HIGH) Z-score at
base line and at yr 1; NY2Y0, number of subjects that had a LOW (or HIGH) Z-score at base line and at yr 2; NY3Y0, number of subjects that had a
LOW (or HIGH) Z-score at base line and at yr 3; NY0, number of subjects that had a LOW (or HIGH) Z-score at baseline. The sample size for N0
varies because some subjects did not have visits in all follow-up years. All races and sexes are combined.

was of similar magnitude to the persistence of height,
weight, and BMI Z-scores.
To investigate the degree of regression toward the
mean, we categorized subjects according to their baseline
Z-score for lumbar spine BMD and calculated the mean
Z-score for each category over time (Fig. 1). Those classified in the highest category at baseline experienced a
small decrease in mean Z-score over time (P ⬍ 0.001), but
mean values still remained higher than those in the cate3

Lumbar spine BMD Z-score

as good as those of height, weight, and BMI Z-scores; most
correlation coefficients differed by less than 5%.
We examined the persistence of values at the tails of the
distribution by categorizing children according to their
baseline Z-score as LOW (⬍⫺1.5) and HIGH (⬎1.5) (Table 2), each constituting approximately 7% of the total
sample. Among those categorized as LOW, 65–77% still
had a LOW bone Z-score after 1 yr, and this decreased to
44 – 62% after 3 yr. Using a more lenient criteria of a
Z-score of less than ⫺1 at follow-up, 72– 87% of children
remained LOW after 3 yr. In contrast, only 3– 4% of those
who had a Z-score of more than ⫺1.5 at baseline had a
Z-score of less than ⫺1.5 after 3 yr. Among children classified as HIGH at baseline, 57–77% still had a HIGH
Z-score after 1 yr, and this decreased to 50 – 62% after 3
yr. Using a criterion of a Z-score greater than 1 at followup, 81– 85% of children remained HIGH after 3 yr. Only
2–5% of those who had a Z-score of less than 1.5 at baseline had a Z-score of more than 1.5 after 3 yr. Overall,
there was no difference in the persistence of LOW or
HIGH Z-scores between boys and girls across skeletal
sites. Race-specific analyses were not performed because
there were too few blacks to allow reliable analyses. Of
note, the persistence of LOW and HIGH bone Z-scores

2
1
0
-1
-2
-3
0

1

2

3

Year

FIG. 1. Mean (⫾SD) lumbar spine BMD Z-score over time. Subjects
were grouped according to their lumbar spine BMD Z-score at
baseline: above 1.5 (n ⫽ 108), 0 to 1.5 (n ⫽ 702), ⫺1.5 to 0 (n ⫽
628), and below ⫺1.5 (n ⫽ 96). Group means significantly differ at all
times points (P ⬍ 0.05).
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gory below (P ⬍ 0.001). Similarly, those classified in the
lowest category at baseline experienced a mean increase in
Z-score over time (P ⬍ 0.001). The yearly change in mean
Z-score was fairly steady over time. Those in middle categories displayed little or no change in mean Z-score over
time. Results were similar for all other skeletal sites (results
not shown).
The degree of tracking over the 3-yr follow-up period
varied according to age at baseline: correlation coefficients
for Z-scores at baseline and yr 3 were highest for the oldest
and youngest children (6 –7 and 14 –16 yr) compared with
children with intermediate ages (Fig. 2). The pattern by
baseline age differed slightly between boys and girls, with
boys generally showing an increase in correlation coefficients at older ages than girls. Likewise, the degree of
tracking was less for children who had begun puberty
compared with those who were either prepubertal (TanBy Age

By Tanner Stage

Correlation coefficient

Correlation coefficient

Correlation coefficient

Correlation coefficient

Correlation coefficient

Girls

Boys

1

1

0.9

Whole body BMC

0.9

0.8

0.8

0.7

0.7

0.6

0.6

0.5

0.5

1

1

0.9

Lumbar spine BMD

0.9

0.8

0.8

0.7

0.7

0.6

0.6

0.5

0.5

1

1

0.9

0.9

Total hip BMD

0.8

0.8

0.7

0.7

0.6

0.6

0.5

0.5

1

1

0.9

0.9
Femoral neck BMD

0.8

0.8

0.7

0.7

0.6

0.6

0.5

0.5

1

1

0.9

1/3 Radius BMD

0.9

0.8

0.8

0.7

0.7

0.6

0.6

0.5

0.5
6- 8- 10- 12- 14- 16
7 9 11 13 15
Age (y)

ner stage 1) or sexually mature (Tanner stage 5) at the
beginning of the 3-yr interval (Fig. 2). Individually,
baseline age explained 2– 4% of the variation in deviation from tracking, and baseline Tanner stage explained 2–9% of the variation in deviation from tracking across skeletal sites.
Change in height status (height-for-age Z-score) was
more strongly correlated with deviation from tracking
than was change in weight status (weight-for-age Z-score)
for whole body BMC and lumbar spine BMD (r ⫽ 0.61
and 0.46 vs. 0.48 and 0.37), but they performed similarly
for the total hip (both r ⫽ 0.41), femoral neck (r ⫽ 0.31
and 0.38), and 1/3 radius BMD (r ⫽ 0.31 and 0.32).
Change in BMI Z-score was weakly correlated with deviation from tracking (r ⫽ 0.23– 0.29).
Because age, sexual maturation, and changes in height
and weight Z-scores are correlated with each other, we
conducted multiple regression analyses to determine
whether they were independently associated with deviation from tracking. Age and Tanner stage at baseline and
change in height and weight Z-scores over the 3-yr follow-up period were significant predictors of deviation
from tracking for all skeletal sites (Table 3). Changes in
height Z-score had a stronger association (i.e. larger ␤-coefficient) than change in weight Z-score for predicting deviation in tracking for whole body and lumbar spine,
whereas there were less distinct trends for predicting
deviation in tracking for the hip and the 1/3 radius. Race
was associated (P ⬍ 0.05) with deviation from tracking,
which likely reflects the different characteristics of
black and non-black participants who did not have a yr
3 visit.
Baseline bone measurements were still highly predictive
of bone measurements 3 yr later, even after adjusting for
the effects of height and weight (Table 4). In regression
models predicting bone Z-scores at yr 3, bone Z-scores at
baseline remained statistically significant (all P ⬍ 0.0001)
for all skeletal sites when including height and weight Zscores at baseline and change in Z-scores over the 3-yr
period. With the exception of whole body BMC, changes
in the magnitude of the regression coefficients for baseline
bone Z-scores and the overall variance explained (model
R2) were small (⬍8%).

Discussion
1 1 2
<7y >8y

3

4

5

Tanner Stage

FIG. 2. Correlation coefficients for Z-scores at baseline and yr 3
according to age, sexual maturation and skeletal site. The pattern in
correlation coefficients according to age is shown on the left, and the
pattern in correlation coefficients according to sexual maturation is
shown on the right.

The clinical utility of bone density measures in childhood
depends largely on the potential of those measures to predict bone mineral status in the future, especially peak adult
BMD. Tracking is a concept that is important for understanding normal physiological bone mineral accrual and is
critical for use of BMD measurements for identifying ab-

a

0
0.15 (⫺0.02, 0.32)
0.47 (0.25, 0.69)
0.63 (0.41,0.86)
0.60 (0.35, 0.85)
0.41 (0.30, 0.51)
0.22 (0.14, 0.30)
0.31
⫺0.11 (⫺0.18, ⫺0.04)
⫺0.07 (⫺0.10, ⫺0.04)
⫺0.09 (⫺0.13, ⫺0.05)

0
0.21 (0.08, 0.33)
0.61 (0.36, 0.86)
0.69 (0.55, 0.85)
0.66 (0.51, 0.82)
0.50 (0.39, 0.61)
0.13 (0.40, 0.22)
0.32
⫺0.02 (⫺0.09, 0.05)
⫺0.06 (⫺0.10, ⫺0.03)
⫺0.09 (⫺0.13, ⫺0.05)
0
⫺0.23 (⫺0.35, ⫺0.11)
⫺0.32 (⫺0.41, ⫺0.24)
⫺0.44 (⫺0.53, ⫺0.35)
⫺0.46 (⫺0.58, ⫺0.33)
0
0.49 (0.36, 0.63)
0.61 (0.49, 0.78)
0.48 (0.36, 0.61)
0.51 (0.38, 0.63)
0.47 (0.38, 0.57)
0.29 (0.21, 0.37)
0.39

0
0.19 (0.07, 0.30)
0.56 (0.42, 0.70)
0.70 (0.58, 0.83)
0.63 (0.50, 0.77)
0.76 (0.62, 0.88)
0.20 (0.12, 0.27)
0.54

0.00 (⫺0.6, 0.7)
⫺0.05 (⫺0.08, ⫺0.02)
⫺0.08 (⫺0.11, ⫺0.4)

0
⫺0.22 (⫺0.30, ⫺0.14)
⫺0.18 (⫺0.29, ⫺0.06)
⫺0.26 (⫺0.42, ⫺0.10)
⫺0.47 (⫺0.65, ⫺0.28)

0
0.40 (0.26, 0.54)
0.55 (0.40, 0.70)
0.49 (0.32, 0.66)
0.44 (0.25, 0.62)
0.63 (0.55, 0.72)
0.29 (0.22, 0.36)
0.52

0
0.42 (0.27, 0.58)
0.47 (0.31, 0.63)
0.39 (0.21, 0.58)
0.32 (0.12, 0.52)
0.34 (0.25, 0.43)
0.40 (0.32, 0.47)
0.39

0
⫺0.20 (⫺0.29, ⫺0.11)
⫺0.28 (⫺0.41, ⫺0.16)
⫺0.18 (⫺0.35, ⫺0.01)
⫺0.20 (⫺0.40, 0.01)

0
⫺0.10 (⫺0.20, 0.00)
⫺0.16 (⫺0.28, ⫺0.04)
⫺0.36 (⫺0.54, ⫺0.18)
⫺0.43 (⫺0.65, ⫺0.21)
⫺0.61 (⫺0.89, ⫺0.33)

0
0.00 (⫺0.16, 0.16)
⫺0.10 (⫺0.22, 0.03)
⫺0.46 (⫺0.57, ⫺0.35)
⫺0.58 (⫺0.72, ⫺0.45)
⫺0.79 (⫺1.02, ⫺0.56)

0
⫺0.03 (⫺0.12, 0.06)
⫺0.20 (⫺0.31, ⫺0.09)
⫺0.43 (⫺0.59, ⫺0.26)
⫺0.61 (⫺0.82, ⫺0.41)
⫺0.97 (⫺1.23, ⫺0.71)

⫺0.02 (⫺0.11, 0.06)
⫺0.09 (⫺0.13, ⫺0.05)
⫺0.12 (⫺0.17, ⫺0.08)

Total hip BMD

0.12 (⫺0.09, 0.10)
⫺0.09 (⫺0.14, ⫺0.04)
⫺0.12 (⫺0.16, ⫺0.07)

Lumbar spine BMD

0.12 (0.04, 0.20)
⫺0.06 (⫺0.10, ⫺0.02)a
⫺0.11 (⫺0.15, ⫺0.07)

Total body BMC

␤ -Coefficient (95% confidence interval).

Boys
Intercept
Z-score Y0
Black
Age Y0
6 –7
8 –9
10 –11
12–13
14 –15
16
Tanner stage Y0
1
2
3
4
5
⌬ Height Z-score
⌬ Weight Z-score
Model R2
Girls
Intercept
Z-score Y0
Black
Age Y0
6 –7
8 –9
10 –11
12–13
14 –15
Tanner stage Y0
1
2
3
4
5
⌬Height Z-score
⌬Weight Z-score
Model R2

TABLE 3. Multiple regression models predicting deviation from tracking (Z-score yr 3 minus Z-score yr 0)

0
0.45 (0.28, 0.61)
0.47 (0.30, 0.65)
0.45 (0.25, 0.65)
0.44 (0.22, 0.66)
0.18 (0.09, 0.28)
0.45 (0.37, 0.54)
0.32

0
⫺0.16 (⫺0.26, ⫺0.06)
⫺0.36 (⫺0.50, ⫺0.23)
⫺0.23 (⫺0.42, ⫺0.05)
⫺0.31 (⫺0.53, ⫺0.09)

⫺0.09 (⫺0.17, ⫺0.01)
⫺0.10 (⫺0.14, ⫺0.07)
⫺0.02 (⫺0.07, 0.02)

0
0.14 (⫺0.04, 0.32)
0.39 (0.16, 0.62)
0.63 (0.39, 0.86)
0.57 (0.31, 0.83)
0.22 (0.12, 0.33)
0.26 (0.17, 0.35)
0.24

0
0.02 (⫺0.08, 0.13)
⫺0.14 (⫺0.26, ⫺0.01)
⫺0.42 (⫺0.60, ⫺0.23)
⫺0.48 (⫺0.70, ⫺0.25)
⫺0.69 (⫺0.98, ⫺0.40)

0.03 (⫺0.06, 0.12)
⫺0.12 (⫺0.16, ⫺0.08)
⫺0.10 (⫺0.13, ⫺0.06)

Femoral neck BMD

0
0.36 (0.17, 0.55)
0.49 (0.21,0.70)
0.35 (0.12, 0.58)
0.32 (0.07, 0.57)
0.20 (0.09, 0.32)
0.23 (0.14, 0.33)
0.22

0
⫺0.16 (⫺0.28, ⫺0.05)
⫺0.44 (⫺0.59, ⫺0.28)
⫺0.46 (⫺0.68, ⫺0.25)
⫺0.47 (⫺0.72, ⫺0.22)

0.16 (0.06, 0.25)
⫺0.14 (⫺0.19, ⫺0.10)
⫺0.06 (⫺0.11, ⫺0.01)

0
0.16 (⫺0.04, 0.36)
0.72 (0.46, 0.98)
0.82 (0.56, 1.09)
0.76 (0.47, 1.06)
0.25 (0.13, 0.37)
0.27 (0.17, 0.37)
0.29

0
⫺0.05 (⫺0.16, 0.07)
⫺0.20 (⫺0.34, ⫺0.06)
⫺0.63 (⫺0.84, ⫺0.42)
⫺0.81 (⫺1.07, ⫺0.55)
⫺1.14 (⫺1.47, ⫺0.80)

0.11 (0.01, 0.22)
⫺0.18 (⫺0.23, ⫺0.13)
⫺0.06 (⫺0.11, ⫺0.00)

1/3 radius BMD
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TABLE 4. Regression coefficients (␤) for baseline (Y0) bone Z-scores predicting bone Z-scores at yr 3 (Y3) with and
without adjusting for height and weight Z-scores
Males
Model
Whole body BMC Z-score
Race, age, Tanner stage
⫹ Ht ZY0, Wt ZY0
⫹ Ht ZY0, Wt ZY0, ⌬Ht Z, ⌬Wt Z
Lumbar spine BMD Z-score
Race, age, Tanner stage
⫹ Ht ZY0, Wt ZY0
⫹ Ht ZY0, Wt ZY0, ⌬Ht Z, ⌬Wt Z
Total hip Z-score
Race, age, Tanner stage
⫹ Ht ZY0, Wt ZY0
⫹ Ht ZY0, Wt ZY0, ⌬Ht Z, ⌬Wt Z
Femoral neck Z-score
Race, age, Tanner stage
⫹ Ht ZY0, Wt ZY0
⫹ Ht ZY0, Wt ZY0, ⌬Ht Z, ⌬Wt Z
1/3 radius Z-score
Race, age, Tanner stage
⫹ Ht ZY0, Wt ZY0
⫹ Ht ZY0, Wt ZY0, ⌬Ht Z, ⌬Wt Z
a

␤-Coefficient (SE)a
for BMD ZY0

Females
Model R2

␤-Coefficient (SE)a
for BMD ZY0

Model R2

0.831 (0.023)
0.765 (0.033)
0.835 (0.026)

0.71
0.71
0.83

0.849 (0.020)
0.820 (0.029)
0.851 (0.022)

0.76
0.76
0.86

0.827 (0.023)
0.808 (0.025)
0.842 (0.024)

0.68
0.68
0.73

0.842 (0.020)
0.838 (0.022)
0.896 (0.020)

0.75
0.75
0.82

0.864 (0.022)
0.855 (0.024)
0.884 (0.022)

0.72
0.72
0.78

0.875 (0.020)
0.878 (0.022)
0.900 (0.019)

0.75
0.75
0.82

0.846 (0.022)
0.844 (0.024)
0.856 (0.023)

0.70
0.70
0.74

0.863 (0.021)
0.873 (0.024)
0.867 (0.022)

0.73
0.73
0.79

0.776 (0.025)
0.760 (0.026)
0.804 (0.025)

0.63
0.63
0.67

0.826 (0.022)
0.823 (0.023)
0.844 (0.023)

0.71
0.71
0.73

All P ⬍ 0.0001.

normalities. Indeed, clinicians have relied upon the characteristic of tracking as justification for routine monitoring of height and weight, which typically remain at
relatively constant percentiles in growing children, to
guide their clinical decisions. We found that BMC and
BMD showed a high degree of tracking over 3 yr of
growth. The degree of tracking of bone mineral accrual
was comparable to height and weight measures in our
sample. It is noteworthy that the degree of tracking of bone
was higher than the degree of tracking of serial changes in
blood pressure (r ⫽ 0.39) (21) and serum cholesterol (r ⫽
0.48 – 0.58) measured in children in other studies (22).
Importantly, we found that children with a low bone mineral status tended to have low bone mineral status 3 yr
later. This finding reinforces the conceptual foundation
for use of BMC and BMD measurements as predictors of
short-term fracture risk during childhood and adolescence. Additional longitudinal measures are necessary to
determine whether these measures adequately predict
peak bone mass and thereby possible risk of osteoporosis
later in life.
That the degree of tracking was slightly less for children
who were at ages of rapid growth and were transitioning
through puberty was not surprising. Although the correlation coefficients between baseline and yr 3 measurements were slightly smaller at ages associated with rapid

linear growth and sexual maturation, the correlation coefficients were still strong (r ⬎ 0.7) for all skeletal sites.
This provides some reassurance to clinicians who must
consider the utility of a bone density assessment when their
patient may soon undergo a period of rapid growth and
maturation. Other smaller studies also have demonstrated
that bone mass and density track across puberty (9 –12).
We addressed the effect of growth on bone density
tracking in two ways. First, we showed that changes in
height and weight Z-scores predicted deviation from
tracking. Interestingly, change in height Z-score over the
3-yr follow-up period was more strongly related to deviation from tracking of the whole body and spine1 than was
change in weight Z-score, whereas they performed similarly for other skeletal sites. This information may be of
use when clinicians evaluate the clinical importance of a
change in bone mineral Z-score determined from a follow-up DXA scan because such changes would be expected in a child who is growing at a different pace relative
to his or her peers. Secondly, like Foley et al. (11), we
showed that baseline bone Z-score was highly predictive
of bone Z-scores 3 yr later, independent of the expected
effects of height and weight and changes in height and
weight.
Despite the strong correlations between measurements
of bone mineral status at baseline and 3 yr later, an indi1

Whole body and spine are the sites recommended for clinical assessment of bone density
in children by the International Society for Clinical Densitometry.
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vidual’s bone mineral status was not perfectly constant
over time. Nonetheless, 72– 87% of children who had a
bone Z-score of less than ⫺1.5 at baseline had a Z-score
of less than ⫺1.0 3 yr later. Importantly, only 3– 4% of
children with a Z-score of more than ⫺1.5 at baseline had
a Z-score less than ⫺1.5 3 yr later.
The diminution of tracking over time, albeit small, illustrates regression toward the mean. Regression toward
the mean is the phenomenon whereby extreme values measured at one point in time are closer to the sample mean
when measured in the future. This occurs as a result of
variation in measurement or when there is variation
within the individual. In this study, measurement error
was introduced by imprecision in DXA measurements and
in calculation of Z-scores. If the diminution in tracking
was just due to error in assigning bone Z-scores at baseline,
then regression toward the mean would have been greatest
between baseline and yr 1 (Fig. 1). This was not the case. The
small continued change in mean Z-scores over time likely
reflects true changes in bone mineral status as well.
From a biological perspective, the presence of tracking in bone mineral status implies several possible mechanisms: 1) bone status is under strong genetic regulation, and the phenotype is manifest by childhood; 2)
nongenetic programming events (e.g. fetal exposures) set
a trajectory for bone mineral status; or 3) environmental
determinants of bone density (e.g. dietary intake, physical
activity) and general health track as well. Several studies
have documented a genetic component to bone mass and
density (23, 24), and heritability studies have demonstrated that mother-daughter resemblance in bone density
is present before puberty (25). As reviewed by Cooper et
al. (26), length and weight at birth, reflecting intrauterine
growth, are positively associated with bone mass in adulthood. Some evidence shows a low to moderate degree of
tracking of dietary intake and physical activity during
childhood and adolescence (27–29). Future studies are
needed to determine the influence of changes in diet and
physical activity on tracking of bone mineral status. These
are particularly important because interventions to alter
trajectories are needed to reduce fracture risk in those individuals with low bone mineral status.
Our findings are limited by a relatively short follow-up
period and lack of peak bone mass measures. It would be
desirable to look at the predictiveness of bone measures
obtained serially from early childhood until peak bone
mass is obtained. Nonetheless, demonstration of tracking
over a 3-yr period is an important first step in demonstrating tracking over a longer period. Our findings over
3 yr of follow-up are consistent with smaller studies of preand early pubertal children that were followed for 7 to 8
yr (9 –11). Also, demonstration of tracking over a 3-yr
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period during childhood and adolescence is important for
clinicians and researchers who are concerned about fractures in childhood and adolescence.
Our findings reflect the natural history of bone mineral
accrual in healthy children. Tracking studies are needed
for children who have chronic medical conditions that
may alter bone mineral accrual and cause fluctuations in
tracking. Our findings show that tracking and the predictiveness of a bone mineral status measurement may diminish over time, requiring follow-up DXA scans to reevaluate bone mineral status.
This study has important strengths. The large sample
size allowed us to examine the tails of the distribution,
which are of clinical concern. We had highly standardized
measurements of bone density measured by DXA, which
currently is recommended by the International Society for
Clinical Densitometry as an appropriate method for bone
density assessment in children and adolescents (30). We
used Z-scores to characterize bone mineral status, making
our findings applicable to pediatricians who need this
measure to evaluate their patients of different ages.
The strong degree of tracking found in this study provides support for use of bone mineral status measurements
in growing children and adolescents. For many children,
low bone mineral status will persist unless interventions
are instituted. Early identification of these children provides a greater opportunity for therapeutic intervention.
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